|
|
Innovate Corp (NYSE: VATE) |
|
Price: $7.4400
$-0.15 
-1.976%
|
| Day's High:
| $7.679999828338623
| Week Perf:
| -3.63 %
|
| Day's Low: |
$ 7.26 |
30 Day Perf: |
-8.37 % |
| Volume (M): |
105,382 |
52 Wk High: |
$ 21.30 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$7.81 |
| Open: |
$7.59 |
52 Wk Low: |
$3.75 |
|
|
| Market Capitalization (Millions $) |
99 |
| Shares
Outstanding (Millions) |
13 |
| Employees |
3,738 |
| Revenues (TTM) (Millions $) |
1,337 |
| Net Income (TTM) (Millions $) |
-55 |
| Cash Flow (TTM) (Millions $) |
101 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Innovate Corp is a cutting-edge technology company that specializes in innovative solutions for businesses. They have a talented team of engineers and developers who are constantly pushing the boundaries of what is possible in terms of technology. They work with clients from various industries to provide customized solutions that meet their unique needs and challenges. Their dedication to innovation sets them apart in the market, helping them create disruptive products and services that revolutionize businesses.
Company Address: 295 Madison Ave. New York 10017 NY
Company Phone Number: 235-2691 Stock Exchange / Ticker: NYSE VATE
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Product Service News
Published Sat, Jan 18 2025 11:46 AM UTC
The U.S. Food and Drug Administration (FDA) has granted approval for the MediBeacon Transdermal Glomerular Filtration Rate (TGFR) system, a significant development in the assessment of kidney function. INNOVATE Corp. (NYSE: VATE), the company behind the technology, announced this milestone on January 17, 2025.The MediBeacon TGFR system is designed to evaluate kidney performa...
|
| Partnership
Published Wed, Nov 20 2024 1:23 PM UTC
In the fast-evolving world of beauty and wellness, innovation drives success. R2 Technologies, Inc. a pioneer in CryoAesthetics, recently announced a series of groundbreaking achievements that underscore its position as a market leader. With a stellar third quarter in 2024, the company, a proud portfolio member of INNOVATE Corp. (NYSE: VATE), has not only showcased its cutti...
|
| Stock Market Announcement
Published Tue, Sep 3 2024 8:05 PM UTC
INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement
NEW YORK, Sept. 03, 2024 - INNOVATE Corp. (NYSE: VATE) (INNOVATE or the Company) announced today that it has received a letter from the New York Stock Exchange (NYSE) dated August 27, 2024 (the Compliance Notice), notifying the Company that it is no longer considered below the NYSE s continued listing ...
|
| Shares
Published Mon, Jul 29 2024 12:30 PM UTC
INNOVATE Corp. (NYSE: VATE), a diversified holding company, recently announced an amendment to the effective date of its 1-for-10 reverse stock split, altering the timeline for the adjustment of its common stock. The reverse stock split, which was previously slated for August 2, 2024, will now become effective on August 8, 2024, after the close of trading on the Ne...
|
| Shares
Published Fri, Jul 19 2024 1:11 PM UTC
Innovate Corp. Announces 1-for-10 Reverse Stock Split, Bringing Share Price to $5.868
NEW YORK, July 19, 2024 - INNOVATE Corp. (INNOVATE or the Company) (NYSE: VATE), a diversified holding company, has recently announced a 1-for-10 reverse stock split of the Company s common stock, par value $0.001 per share (Common Stock). The reverse stock split is set to take effect a...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-4.26 $ |
| Revenues (TTM) |
100.16 $
|
| Cash Flow (TTM) |
7.59 $ |
| Cash |
10.09 $
|
| Book Value |
-
|
| Dividend (TTM) |
0.02 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
357,571 |
| Net
Income per Employee (TTM) |
-14,794 |
| Receivable Turnover Ratio (TTM) |
5.72 |
| Inventory Turnover Ratio (TTM) |
64.32 |
| Asset Turnover Ratio (TTM) |
1.45 |
|
|
| Per Share |
|
| Earnings (TTM) |
-4.26 $
|
| Revenues (TTM) |
100.16 $ |
| Cash Flow (TTM) |
7.59 $ |
| Cash |
10.09 $
|
| Book Value |
- |
| Dividend (TTM) |
0.02 $ |
|
|
| |
| Infrastructure |
|
 98.11 % |
of total Revenue |
| Life Sciences |
|
0.44 % |
of total Revenue |
| Spectrum |
|
1.45 % |
of total Revenue |
| Infrastructure Industrial |
|
34.59 % |
of total Revenue |
| Infrastructure Commercial |
|
29.61 % |
of total Revenue |
| Infrastructure Healthcare |
|
11.38 % |
of total Revenue |
| Infrastructure Government |
|
10.17 % |
of total Revenue |
| Infrastructure Transportation |
|
9.38 % |
of total Revenue |
| Infrastructure Energy |
|
2.6 % |
of total Revenue |
| Infrastructure Leisure |
|
0.05 % |
of total Revenue |
| Infrastructure Convention |
|
0.25 % |
of total Revenue |
| Systems and consumables revenue |
|
0.44 % |
of total Revenue |
| Broadcast station |
|
1.45 % |
of total Revenue |
|
|
0.99%